Ipsen
Develops transformative medicines for Oncology, Rare Diseases, and Neuroscience.
IPN | PA
Overview
Corporate Details
- ISIN(s):
- FR0010259150 (+17 more)
- LEI:
- 549300M6SGDPB4Z94P11
- Country:
- France
- Address:
- 65 QUAI GEORGES GORSE, 92100 BOULOGNE-BILLANCOURT
- Website:
- https://www.ipsen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs for patients. Its core business activities are concentrated in three key therapeutic areas: Oncology, Rare Diseases, and Neuroscience. Ipsen leverages its specialized expertise, global infrastructure, and strategic partnerships to accelerate its research pipeline and bring new therapies to market. The firm's strategy emphasizes advancing science with purpose to improve and extend the lives of people living with complex conditions.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Ipsen and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-16 18:30 |
Transaction in Own Shares
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - …
|
English | 86.5 KB | |
| 2025-09-16 18:30 |
Transaction in Own Shares
IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2025
|
English | 86.4 KB | |
| 2025-09-02 18:00 |
Transaction in Own Shares
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - …
|
French | 269.9 KB | |
| 2025-09-02 18:00 |
Transaction in Own Shares
IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2025
|
English | 542.0 KB | |
| 2025-07-10 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Ipsen - Juin 2025 - Information mensuelle relative au nombre total des droits d…
|
French | 124.2 KB | |
| 2025-07-10 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Ipsen - June 2025 - Monthly information relative to the total number of voting …
|
English | 106.7 KB | |
| 2025-07-01 09:00 |
Environmental & Social Information
Gemeinsam fur eine bessere Zukunft: Ipsen Pharma GmbH engagiert sich am Communi…
|
German | 8.6 KB | |
| 2025-06-17 18:00 |
Transaction in Own Shares
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2025
|
English | 271.6 KB | |
| 2025-06-17 18:00 |
Transaction in Own Shares
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - …
|
English | 468.0 KB | |
| 2025-06-13 18:00 |
Transaction in Own Shares
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025
|
English | 324.3 KB | |
| 2025-06-13 18:00 |
Transaction in Own Shares
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - …
|
English | 293.1 KB | |
| 2025-06-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Ipsen - May 2025 - Monthly information relative to the total number of voting r…
|
English | 106.5 KB | |
| 2025-06-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Ipsen - Mai 2025 - Information mensuelle relative au nombre total des droits de…
|
French | 145.2 KB | |
| 2025-06-10 14:51 |
Major Shareholding Notification
Franchissement de seuil
|
French | 125.2 KB | |
| 2025-06-02 07:00 |
Transaction in Own Shares
Ipsen S.A. - Initiation of the share buy-back program
|
English | 104.2 KB |
Automate Your Workflow. Get a real-time feed of all Ipsen filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Ipsen via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-04 | N/A | Other | Sell | 850 | 91,374.66 EUR |
| 2024-02-27 | N/A | Other | Buy | 500 | 51,916.20 EUR |
| 2023-07-31 | N/A | Other | Buy | 50,048 | N/A |
